Australian Clinical Labs Dividends and Buybacks
Dividend criteria checks 2/6
Australian Clinical Labs is a dividend paying company with a current yield of 3.2%.
Key information
3.2%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 3.4% |
| Future Dividend Yield | 4.4% |
| Dividend Growth | -13.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | AU$0.120 |
| Payout ratio | 100% |
Recent dividend and buyback updates
Recent updates
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge
Sep 03
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?
Sep 02We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt
Jun 20Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?
Feb 21Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Dec 08Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today
Aug 14Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)
Dec 22The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More
Dec 21The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business
Sep 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ACL has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ACL has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Australian Clinical Labs Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ACL) | 3.2% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.1% |
| Industry Average (Healthcare) | 2.7% |
| Analyst forecast (ACL) (up to 3 years) | 4.4% |
Notable Dividend: ACL's dividend (3.2%) is higher than the bottom 25% of dividend payers in the Australian market (2.61%).
High Dividend: ACL's dividend (3.2%) is low compared to the top 25% of dividend payers in the Australian market (6.08%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (99.7%), ACL's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (15.6%), ACL's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 07:20 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Australian Clinical Labs Limited is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lyanne Harrison | BofA Global Research |
| Mathieu Chevrier | Citigroup Inc |
| Gretel Janu | Credit Suisse |